Trials / Unknown
UnknownNCT04506229
Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Texas Cardiac Arrhythmia Research Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
There is a considerable variation in the disease behavior in terms of contracting the infection, manifesting none to a range of symptoms and severity of the infection among individuals exposed to or infected with SARS-CoV-2 virus, the causative organism of COVID-19. Although the respiratory system appears to be the primary target of this virus infection, emerging evidences suggests involvement of extra-pulmonary organs including central nervous system. We aim to compare the genetic profile of individuals with vs without COVID-19 after being exposed to infected cases. Additionally, we will assess the cognitive function in covid-19 positive cases with vs. without neurological symptoms at the time of infection and 1-month follow-up using the Montreal Cognitive Assessment (MoCA) questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Whole exome sequencing | MoCA survey to evaluate cognitive function in COVID-19 positive cases with vs without neurological symptoms |
Timeline
- Start date
- 2020-08-20
- Primary completion
- 2021-08-01
- Completion
- 2021-09-01
- First posted
- 2020-08-10
- Last updated
- 2020-08-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04506229. Inclusion in this directory is not an endorsement.